Safety and Efficacy of OD-07656 and of Subsequent Vedolizumab Therapy in Moderately to Severely Active Ulcerative Colitis

Clinical trial NCT06850727 · RECRUITING

Trial details

NCT number: NCT06850727
Sponsor: Odyssey Therapeutics
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Ulcerative Colitis (UC)UC - Ulcerative Colitis

Start date: 2025-06-02
Primary completion: 2026-04-01
Enrollment: 57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.